Sotgia, F., & Lisanti, M. P. (2017). Mitochondrial markers predict survival and progression in non-small cell lung cancer (NSCLC) patients: Use as companion diagnostics. Oncotarget.
Stile di citazione ChicagoSotgia, Federica, e Michael P. Lisanti. "Mitochondrial Markers Predict Survival and Progression in Non-small Cell Lung Cancer (NSCLC) Patients: Use As Companion Diagnostics." Oncotarget 2017.
Citazione MLASotgia, Federica, e Michael P. Lisanti. "Mitochondrial Markers Predict Survival and Progression in Non-small Cell Lung Cancer (NSCLC) Patients: Use As Companion Diagnostics." Oncotarget 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.